Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 7Terminated 4Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Brain Neoplasms 23Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 11Neoplasm Metastasis 8Melanoma 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Carcinoma, Renal Cell 4Small Cell Lung Carcinoma 3Meningioma 3Urinary Bladder Neoplasms 2Sarcoma 2Prostate Adenocarcinoma 2Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1

Interventions

pembrolizumab 22Cisplatin 17Surveys and Questionnaires 8Radiotherapy 8Carboplatin 8Radiotherapy, Intensity-Modulated 7Cetuximab 7Paclitaxel 6Nivolumab 6Drug Therapy 6Radiation 4Fluorouracil 4Taxes 3Docetaxel 3selpercatinib 2dostarlimab 2Yoga 2Surgical Procedures, Operative 2Standard of Care 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Chemoradiotherapy 2Blood Specimen Collection 2ALX148 2veliparib 1tisotumab vedotin 1tislelizumab 1palbociclib 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Head and Neck Neoplasms × Radiosurgery × Clear all
NCT04938609 2026-04-09

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Providence Health & Services

Phase 2 Active not recruiting
28 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02474368 2025-07-10

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Dana-Farber Cancer Institute

Phase 1 Active not recruiting
21 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡